Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has issued an announcement.
Dawnrays Pharmaceutical Holdings Ltd. announced an interim cash dividend of HKD 0.015 per share for the six months ending June 30, 2025. The ex-dividend date is set for September 16, 2025, with the payment date scheduled for October 3, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may influence investor sentiment positively.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical products. The company is primarily engaged in providing a range of medical solutions, with a market focus on delivering high-quality healthcare products.
Average Trading Volume: 2,258,459
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$1.97B
See more data about 2348 stock on TipRanks’ Stock Analysis page.